Success Stories

24

2026

-

09

Exhibition Highlights | Pharmed & Healthcare Vietnam 2026


Author:


Ho Chi Minh City, Vietnam

Pharmed & Healthcare Vietnam 2026


Entering Saigon: The Vanguard of ASEAN




September 22–24, 2026

Pharmed & Healthcare Vietnam 2026

Held at the Saigon Exhibition and Convention Center in Ho Chi Minh City.

Over 600 exhibiting companies

Over 12,000 square meters of exhibition space

96 Chinese enterprises made a collective appearance.

This is the performance report for this year’s flagship exhibition in Vietnam’s healthcare sector.










Entering Vietnam

A $1.8 billion import-dependent market




The size of Vietnam’s medical device market is larger than most people imagine.


Vietnam’s medical device market has been growing at an annual average rate of 8.3% and is projected to reach US$2.89 billion by 2031. At a working session of the Ministry of Health on September 8, 2026, Prime Minister Pham Minh Chinh stated that the Vietnamese medical device industry was valued at approximately US$2 billion in 2025.



A more critical structural feature is that over 90% of medical devices are imported. Across Vietnam, there are roughly 1,600 hospitals, with public hospitals accounting for more than 1,200 and meeting nearly 60% of the country’s equipment procurement needs.


The Vietnamese government is advancing the modernization and upgrading of public hospitals, which has directly boosted demand for medical equipment; however, domestic manufacturing capacity remains limited.


Domestic production capacity is primarily concentrated in low-value consumables and simple medical devices. High-end imaging, surgical equipment, and in vitro diagnostics are almost entirely reliant on imports.

This provides Chinese enterprises with a market characterized by clear structural opportunities.




The flagship of the Vietnam Medical Exhibition

The Chinese delegation boasts formidable strength.



Pharmed & Healthcare Vietnam is co-organized by GLOEX and Informa Markets, with the support of the Vietnamese Ministry of Health, and has been held for more than 20 editions to date.



This year’s exhibition is being held concurrently with RAVEX (Rehabilitation Aids Expo) and Eldercare Expo (Elderly Care Exhibition), and for the first time features an international symposium, with topics covering healthcare industry growth, the application of AI in medical devices, hospital management, and more.



Over 600 exhibiting companies from more than 20 countries and regions; an exhibition space exceeding 12,000 square meters; an estimated attendance of over 12,000 professional visitors; covering the entire pharmaceutical industry chain, from active pharmaceutical ingredients and finished drugs to medical devices, laboratory instruments, hospital equipment, and rehabilitation and nursing services.


It also features B2B matchmaking, LeadGrab, and other business‑to‑business networking events.


At this year’s exhibition, 96 Chinese companies participated. , with a net exhibition area of nearly 1,100 square meters, covering multiple sub-sectors including medical devices, pharmaceutical equipment, laboratory instruments, and medical consumables.



China is Vietnam’s largest supplier of medical devices, accounting for 26.2% of Vietnam’s medical device imports, with import value totaling approximately US$492 million—far surpassing Japan, the European Union, and the United States.



The China–ASEAN Regional Pharmaceutical Trading (Centralized Procurement) Platform is accelerating the entry of Chinese medical devices into the Vietnamese market. As of September 2026, the platform has facilitated the registration and market launch of 62 medical device products from 29 Chinese companies in Vietnam. In July 2026, a domestically developed intelligent surgical robot obtained registration in Vietnam through this platform, becoming the first Chinese intelligent surgical robot to enter the Vietnamese market; in early August, it performed its first two-way remote robotic surgery in Hanoi and Can Tho.



These data and policy changes indicate that many Chinese enterprises have entered the Vietnamese market and have long since established a “systematic strategic presence.”



The Other Side of the Market

The opportunities are substantial, but the entry barrier is high.



While the Vietnamese market offers ample opportunities, cultivating it effectively is far from straightforward.


Vietnam is not a market where you can close deals simply by showing up.


Vietnam’s medical device registration requires the appointment of a local authorized representative, and all documentation must be translated into Vietnamese. Class C and Class D devices have relatively lengthy approval cycles. As of March 2026, the Vietnam Ministry of Health’s medical device registry lists 108,658 valid registrations under 21,871 applicants, reflecting a highly fragmented market: the top 50 applicants account for only 18.2% of the total registrations. This underscores the critical importance of identifying a reliable local partner.


Extremely price-sensitive


In Vietnam, public hospitals still rely primarily on tendering for procurement, with the lowest‑price winner being the norm. Even if a product boasts technological advantages, an uncompetitive cost structure can make it difficult to secure a contract in the bidding process. Competition in categories such as consumables and basic patient monitoring equipment is already extremely fierce.


After-sales service is a hard barrier.


In recent years, Vietnam’s Ministry of Health has continuously strengthened the development of its medical equipment quality management system. In December 2025, it issued Notice No. 59, stipulating that all medical devices procured after June 30, 2026, must pass safety and technical‑functional inspections. Insufficient equipment maintenance capabilities are a common factor affecting customer repurchase rates.


In summary, Pharmed & Healthcare Vietnam is an excellent platform for gaining market insights and establishing initial connections, but a single trade show cannot solve all challenges. Successful market entry requires systematic investments in areas such as regulatory registration, distribution channels, after-sales support, and localization. Trade shows should be viewed as the first step in market research and relationship-building, rather than the final push.




Jiayu was present throughout the entire process.

We’re here to support you around the clock.



At this year’s Vietnam exhibition, Jiayu’s local service team was on-site throughout the event.

We not only provide upfront support such as visa assistance, logistics, exhibit customs clearance, and booth‑construction coordination; we also maintain an on‑site team that works seamlessly with our domestic operations center around the clock, ensuring end‑to‑end responsiveness—from customer‑driven iterations to emergency‑response handling.


No matter where you are

Regardless of size

We consistently deliver top-quality service!


About Us

Choose Jiayu International—go global with greater confidence! Led by seasoned professionals with two decades of experience in international exhibitions, our team leverages a global perspective, deep industry insights, and a well-established network of overseas resources to deliver a one-stop service platform that covers the world’s leading medical trade shows. We provide Chinese healthcare companies with comprehensive, internationally aligned solutions for exhibition participation and market expansion.


Turn every trade show into a stream of orders!

Next session time

Pharmed & Healthcare Vietnam 2027

September 28–30, 2027

Ho Chi Minh City, Vietnam

See you then!








Follow us to instantly access the 2027 Global Trade Show Guide.



For detailed information about the exhibits and cutting-edge industry insights, please follow Jiayu International’s video channel and tune in to our “Corporate Interviews” series.










Key words:

Latest Case

undefined

undefined